ACUTUS MEDICAL INC (AFIB)
US0051111096 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.17M | 25.60M | 24.10M | 25.20M | 9.50M | |||
| Marketable Securities | 3.23M | 44.90M | 76.70M | 105.80M | 62.40M | |||
| Receivables | 11.35M | 21.10M | 3.60M | 2.20M | 300.00K | |||
| Inventories | 4.28M | 13.30M | 16.40M | 13.00M | 8.40M | |||
| Other Current Assets | 8.22M | 13.00M | 5.50M | 5.20M | 2.00M | |||
| Total Current Assets | 46.25M | 117.90M | 126.30M | 151.40M | 82.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.01M | 13.10M | 18.20M | 14.00M | 6.80M | |||
| Investments And Advances | N/A | 0.00 | 7.10M | 8.70M | N/A | |||
| Goodwill | N/A | 0.00 | 12.00M | 12.00M | 12.00M | |||
| Intangibles | 0.00 | 1.60M | 5.00M | 5.70M | 4.10M | |||
| Other Non-Current Assets | 3.69M | 900.00K | 1.20M | 700.00K | 100.00K | |||
| Total Non-Current Assets | 7.71M | 15.50M | 43.50M | 41.10M | 23.00M | |||
| TOTAL ASSETS | 53.96M | 133.40M | 169.80M | 192.50M | 105.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.86M | 1.80M | 1.50M | 5.40M | 8.20M | |||
| Accrued Expenses | 3.60M | 9.70M | 9.10M | 7.90M | 10.60M | |||
| Accounts Payable | 2.76M | 4.70M | 7.50M | 8.30M | 3.90M | |||
| Other Current Liabilities | 10.71M | 3.70M | 400.00K | 300.00K | 9.20M | |||
| Total Current Liabilities | 18.94M | 19.90M | 18.50M | 21.90M | 31.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 32.65M | 34.40M | 40.90M | 42.90M | 43.90M | |||
| Other Non-Current Liabilities | 3.24M | 4.10M | 4.60M | 1.10M | 2.10M | |||
| Total Non-Current Liabilities | 35.90M | 38.50M | 45.60M | 44.10M | 46.00M | |||
| TOTAL LIABILITIES | 54.84M | 58.40M | 64.10M | 66.00M | 77.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -599.98M | -518.30M | -478.70M | -361.00M | -259.00M | |||
| Additional Paid In Capital | 599.93M | 594.20M | 584.60M | 487.30M | 33.20M | |||
| Common Shares | 29.00K | 0.00 | 0.00 | 0.00 | 253.40M | |||
| Other Shareholders' Equity | -866.00K | -900.00K | -200.00K | 300.00K | 0.00 | |||
| Shares Outstanding | 28.55M | 28.60M | 28.00M | 28.00M | 24.60M | |||
| Tangible Book Value per Share | -0.03 | 2.57 | 3.17 | 3.89 | -9.84 | |||
| Total Shareholders' Equity | -879.00K | 75.00M | 105.70M | 126.60M | 27.50M | |||
| TOTAL LIABILITIES AND EQUITY | 53.96M | 133.40M | 169.80M | 192.50M | 105.50M | |||
| Statistics | ||||||||
| Debt/Equity | -37.15 | 0.46 | 0.39 | 0.34 | 1.60 | |||
| Current Ratio | 2.44 | 5.92 | 6.83 | 6.91 | 2.59 | |||
| Return On Assets (ROA) | -151.34% | -29.70% | -69.31% | -52.98% | -91.98% | |||
| Return On Equity (ROE) | N/A | -52.83% | -111.33% | -80.55% | -352.87% | |||
All data in USD